Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- PMID: 32938692
- DOI: 10.1136/gutjnl-2020-322572
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Abstract
Objective: Follow-up studies have shown that non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of incident diabetes, but currently, it is uncertain whether this risk changes with increasing severity of NAFLD. We performed a meta-analysis of relevant studies to quantify the magnitude of the association between NAFLD and risk of incident diabetes.
Design: We systematically searched PubMed, Scopus and Web of Science databases from January 2000 to June 2020 using predefined keywords to identify observational studies with a follow-up duration of at least 1 year, in which NAFLD was diagnosed by imaging techniques or biopsy. Meta-analysis was performed using random-effects modelling.
Results: 33 studies with 501 022 individuals (30.8% with NAFLD) and 27 953 cases of incident diabetes over a median of 5 years (IQR: 4.0-19 years) were included. Patients with NAFLD had a higher risk of incident diabetes than those without NAFLD (n=26 studies; random-effects HR 2.19, 95% CI 1.93 to 2.48; I2 =91.2%). Patients with more 'severe' NAFLD were also more likely to develop incident diabetes (n=9 studies; random-effects HR 2.69, 95% CI 2.08 to 3.49; I2 =69%). This risk markedly increased across the severity of liver fibrosis (n=5 studies; random-effects HR 3.42, 95% CI 2.29 to 5.11; I2=44.6%). All risks were independent of age, sex, adiposity measures and other common metabolic risk factors. Sensitivity analyses did not alter these findings. Funnel plots did not reveal any significant publication bias.
Conclusion: This updated meta-analysis shows that NAFLD is associated with a ~2.2-fold increased risk of incident diabetes. This risk parallels the underlying severity of NAFLD.
Keywords: diabetes mellitus; liver; meta-analysis; nonalcoholic steatohepatitis.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
NAFLD und Diabetes sind beste Freunde.MMW Fortschr Med. 2021 Nov;163(19):31. doi: 10.1007/s15006-021-0491-6. MMW Fortschr Med. 2021. PMID: 34708367 Review. German. No abstract available.
-
Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study.Gut. 2023 May;72(5):1020-1022. doi: 10.1136/gutjnl-2022-327504. Epub 2022 Jun 20. Gut. 2023. PMID: 35725292 No abstract available.
-
Non-alcoholic fatty liver disease is associated with an increased risk of type 2 diabetes.Eur J Gastroenterol Hepatol. 2023 Jun 1;35(6):662-667. doi: 10.1097/MEG.0000000000002555. Epub 2023 Apr 15. Eur J Gastroenterol Hepatol. 2023. PMID: 37115964
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical